Tevogen Bio's Business Model Addresses Biopharma Industry Challenges with Cost-Efficient Innovation
Go back to Tevogen Bio's Business Model Addresses Biopharma Industry Challenges with Cost-Efficient Innovation| (NASDAQ: TVGN) | Delayed: 6.42 +0.11 (1.74%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.31 | 52 Week High | $ | |||
| Open | $6.50 | 52 Week Low | $ | |||
| Day High | $6.50 | P/E | N/A | |||
| Day Low | $6.00 | EPS | $ | |||
| Volume | 9,097 | |||||
| (NASDAQ: TVGNW) | Delayed: 0.05 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.05 | 52 Week High | $ | |||
| Open | $0.04 | 52 Week Low | $ | |||
| Day High | $0.05 | P/E | N/A | |||
| Day Low | $0.04 | EPS | $ | |||
| Volume | 13,238 | |||||
